QQ客服 官方微博 反馈留言

	XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled Trial
	Song, Yuanlin; Yao, Chen; Yao, Yongming; Han, Hui; Zhao, Xiaodong; Yu, Kaijiang; Liu, Luyi; Xu, Ying; Liu, Zhongmin; Zhou, Qingshan
刊名	CRITICAL CARE MEDICINE
	2019
卷号	47期号:9
关键词	28-day mortality rate pneumonia severity index randomized controlled trial severe community-acquired pneumonia XueBiJing injection
ISSN号	0090-3493
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3598026
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Song, Yuanlin,Yao, Chen,Yao, Yongming,et al. XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled Trial[J]. CRITICAL CARE MEDICINE,2019,47(9).
APA	Song, Yuanlin.,Yao, Chen.,Yao, Yongming.,Han, Hui.,Zhao, Xiaodong.,...&Bai, Chunxue.(2019).XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled Trial.CRITICAL CARE MEDICINE,47(9).
MLA	Song, Yuanlin,et al."XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled Trial".CRITICAL CARE MEDICINE 47.9(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。